BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

494 related articles for article (PubMed ID: 24745674)

  • 1. Epidemiology, prognosis, and risk factors in mastocytosis.
    Brockow K
    Immunol Allergy Clin North Am; 2014 May; 34(2):283-95. PubMed ID: 24745674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug allergy in mastocytosis.
    Bonadonna P; Lombardo C
    Immunol Allergy Clin North Am; 2014 May; 34(2):397-405. PubMed ID: 24745682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic value of tryptase in anaphylaxis and mastocytosis.
    Schwartz LB
    Immunol Allergy Clin North Am; 2006 Aug; 26(3):451-63. PubMed ID: 16931288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clonal mast cell disorders in patients with systemic reactions to Hymenoptera stings and increased serum tryptase levels.
    Bonadonna P; Perbellini O; Passalacqua G; Caruso B; Colarossi S; Dal Fior D; Castellani L; Bonetto C; Frattini F; Dama A; Martinelli G; Chilosi M; Senna G; Pizzolo G; Zanotti R
    J Allergy Clin Immunol; 2009 Mar; 123(3):680-6. PubMed ID: 19135713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mast Cell Disorders In Drug Hypersensitivity.
    Bonadonna P; Bonifacio M; Zanotti R
    Curr Pharm Des; 2016; 22(45):6862-6869. PubMed ID: 27779084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mastocytosis: state of the art.
    Horny HP; Sotlar K; Valent P
    Pathobiology; 2007; 74(2):121-32. PubMed ID: 17587883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anaphylaxis in patients with mastocytosis: a study on history, clinical features and risk factors in 120 patients.
    Brockow K; Jofer C; Behrendt H; Ring J
    Allergy; 2008 Feb; 63(2):226-32. PubMed ID: 18186813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathology of extramedullary mastocytosis.
    Doyle LA; Hornick JL
    Immunol Allergy Clin North Am; 2014 May; 34(2):323-39. PubMed ID: 24745677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonaggressive systemic mastocytosis (SM) without skin lesions associated with insect-induced anaphylaxis shows unique features versus other indolent SM.
    Alvarez-Twose I; Zanotti R; González-de-Olano D; Bonadonna P; Vega A; Matito A; Sánchez-Muñoz L; Morgado JM; Perbellini O; García-Montero A; De Matteis G; Teodósio C; Rossini M; Jara-Acevedo M; Schena D; Mayado A; Zamò A; Mollejo M; Sánchez-López P; Cabañes N; Orfao A; Escribano L; ;
    J Allergy Clin Immunol; 2014 Feb; 133(2):520-8. PubMed ID: 23921094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High prevalence of anaphylaxis in patients with systemic mastocytosis - a single-centre experience.
    Gülen T; Hägglund H; Dahlén B; Nilsson G
    Clin Exp Allergy; 2014 Jan; 44(1):121-9. PubMed ID: 24164252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Venom immunotherapy in patients with mastocytosis and hymenoptera venom anaphylaxis.
    González-de-Olano D; Alvarez-Twose I; Vega A; Orfao A; Escribano L
    Immunotherapy; 2011 May; 3(5):637-51. PubMed ID: 21554093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anaphylaxis with clonal mast cells in normal looking skin - a new entity?
    Bretterklieber A; Beham-Schmid C; Sturm GJ; Berghold A; Brezinschek R; Aberer W; Aberer E
    Allergy; 2015 Jul; 70(7):864-72. PubMed ID: 25899109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis, progression patterns and prognostication in mastocytosis.
    Sperr WR; Valent P
    Expert Rev Hematol; 2012 Jun; 5(3):261-74. PubMed ID: 22780207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cutaneous manifestations in Hymenoptera and Diptera anaphylaxis: relationship with basal serum tryptase.
    Potier A; Lavigne C; Chappard D; Verret JL; Chevailler A; Nicolie B; Drouet M
    Clin Exp Allergy; 2009 May; 39(5):717-25. PubMed ID: 19302252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stinging Hymenoptera and mastocytosis.
    Ruëff F; Dugas-Breit S; Przybilla B
    Curr Opin Allergy Clin Immunol; 2009 Aug; 9(4):338-42. PubMed ID: 19474708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of Mediator Symptoms, Allergy, and Anaphylaxis in Mastocytosis.
    Gulen T
    Immunol Allergy Clin North Am; 2023 Nov; 43(4):681-698. PubMed ID: 37758406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Idiopathic Anaphylaxis: A Form of Mast Cell Activation Syndrome.
    Giannetti MP; Akin C; Castells M
    J Allergy Clin Immunol Pract; 2020 Apr; 8(4):1196-1201. PubMed ID: 32276688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How to interpret mast cell tests.
    Waterfield T; Dyer E; Wilson K; Boyle RJ
    Arch Dis Child Educ Pract Ed; 2016 Oct; 101(5):246-51. PubMed ID: 27325614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Mastocytosis: when should it be considered?].
    Comte-Perret S; Bart PA; Spertini F; Leimgruber A
    Rev Med Suisse; 2009 Apr; 5(199):837-42. PubMed ID: 19441750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tryptase levels as an indicator of mast-cell activation in systemic anaphylaxis and mastocytosis.
    Schwartz LB; Metcalfe DD; Miller JS; Earl H; Sullivan T
    N Engl J Med; 1987 Jun; 316(26):1622-6. PubMed ID: 3295549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.